Table 1.

Demographics and baseline characteristics of DLBCL patients in the Ro+R-CHOP trial.

UPN	Gender/Age	Ethnicity	ECOG PS	R-IPI	Lugano Stage	Double MYC/BCL2 Expressors
1	M/53	non-Hispanic	1	2	IIIB	NA
2	M/69	Hispanic	1	4	IIIE	Yes
3	F/79	Hispanic	1	2	IIB	Yes
4	M/33	Unknown	0	0	IIE	No
7	F/64	Hispanic	0	3	IV	Yes
9	M/67	non-Hispanic	1	1	IIE	No
11	M/49	non-Hispanic	0	NA	IV	No
12	F/72	Hispanic	0	2	II	No
13	F/55	non-Hispanic	0	1	IIE	Yes
14	M/56	Hispanic	0	2	IV	Yes